Celltrion Healthcare, Foreigners Net Sell 8,000 Shares... Stock Price -0.63%
As of 10:31 AM on the 10th, Celltrion Healthcare is trading at 141,400 KRW, down 0.63% from the previous day. This represents a 16.73% decline compared to January 13. Celltrion Healthcare is known as the exclusive distributor of Celltrion's biosimilars.
Today, foreigners are estimated to have net sold 8,000 shares of Celltrion Healthcare, while institutions have net sold 1,000 shares. Over the past five days, individual investors have net bought 182,770 shares, whereas foreigners and institutions have net sold 131,340 shares and 65,231 shares, respectively.
Hot Picks Today
!["It Has Now Crossed Borders": No Vaccine or Treatment as Bundibugyo Ebola Variant Spreads [Reading Science]](https://cwcontent.asiae.co.kr/asiaresize/93/2026052019230771274_1779272587.jpg)
"It Has Now Crossed Borders": No Vaccine or Treatment as Bundibugyo Ebola Variant Spreads [Reading Science]
- "Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Even With a 90 Million Won Salary and Bonuses, It Doesn’t Feel Like Much"... A Latecomer Rookie Who Beat 70 to 1 Odds [Scientists Are Disappearing] ③
- "Am I Really in the Top 30%?" and "Worried About My Girlfriend in the Bottom 70%"... Buzz Over High Oil Price Relief Fund
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
※ Source: AI Investment Assistant AI Rassiro
※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
